Jamieson Bondarenko - Net Worth and Insider Trading

Jamieson Bondarenko Net Worth

The estimated net worth of Jamieson Bondarenko is at least $258,181 dollars as of 2024-05-22. Jamieson Bondarenko is the Chairman of BriaCell Therapeutics Corp and owns about 169,856 shares of BriaCell Therapeutics Corp (BCTX) stock worth over $258,181. Details can be seen in Jamieson Bondarenko's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jamieson Bondarenko has not made any transactions after 2022-12-28 and currently still holds the listed stock(s).

Transaction Summary of Jamieson Bondarenko

To

Jamieson Bondarenko Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jamieson Bondarenko owns 1 companies in total, including BriaCell Therapeutics Corp (BCTX) .

Click here to see the complete history of Jamieson Bondarenko’s form 4 insider trades.

Insider Ownership Summary of Jamieson Bondarenko

Ticker Comapny Transaction Date Type of Owner
BCTX BriaCell Therapeutics Corp 2022-12-28 director

Jamieson Bondarenko Latest Holdings Summary

Jamieson Bondarenko currently owns a total of 1 stock. Jamieson Bondarenko owns 169,856 shares of BriaCell Therapeutics Corp (BCTX) as of December 28, 2022, with a value of $258,181.

Latest Holdings of Jamieson Bondarenko

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCTX BriaCell Therapeutics Corp 2022-12-28 169,856 1.52 258,181

Holding Weightings of Jamieson Bondarenko


Jamieson Bondarenko Form 4 Trading Tracker

According to the SEC Form 4 filings, Jamieson Bondarenko has made a total of 2 transactions in BriaCell Therapeutics Corp (BCTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in BriaCell Therapeutics Corp is the acquisition of 28,000 shares on December 28, 2022, which cost Jamieson Bondarenko around $128,240.

Insider Trading History of Jamieson Bondarenko

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jamieson Bondarenko Trading Performance

GuruFocus tracks the stock performance after each of Jamieson Bondarenko's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jamieson Bondarenko is 42.45%. GuruFocus also compares Jamieson Bondarenko's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jamieson Bondarenko within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jamieson Bondarenko's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jamieson Bondarenko

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 49.86
Relative Return to S&P 500(%) 44.08

Jamieson Bondarenko Ownership Network

Ownership Network List of Jamieson Bondarenko

No Data

Ownership Network Relation of Jamieson Bondarenko


Jamieson Bondarenko Owned Company Details

What does BriaCell Therapeutics Corp do?

Who are the key executives at BriaCell Therapeutics Corp?

Jamieson Bondarenko is the director of BriaCell Therapeutics Corp. Other key executives at BriaCell Therapeutics Corp include CFO & Secretary Gadi Levin , Chief Medical Officer Priore Giuseppe Del , and director & President & CEO Williams V. Williams .

BriaCell Therapeutics Corp (BCTX) Insider Trades Summary

Over the past 18 months, Jamieson Bondarenko made 2 insider transaction in BriaCell Therapeutics Corp (BCTX) with a net purchase of 50,000. Other recent insider transactions involving BriaCell Therapeutics Corp (BCTX) include a net purchase of 902,935 shares made by Marc Lustig ,

In summary, during the past 3 months, insiders sold 0 shares of BriaCell Therapeutics Corp (BCTX) in total and bought 902,935 shares, with a net purchase of 902,935 shares. During the past 18 months, 0 shares of BriaCell Therapeutics Corp (BCTX) were sold and 952,935 shares were bought by its insiders, resulting in a net purchase of 952,935 shares.

BriaCell Therapeutics Corp (BCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BriaCell Therapeutics Corp Insider Transactions

No Available Data

Jamieson Bondarenko Mailing Address

Above is the net worth, insider trading, and ownership report for Jamieson Bondarenko. You might contact Jamieson Bondarenko via mailing address: 402-1 Scott St.`, Toronto A6 M5e 1a1.

Discussions on Jamieson Bondarenko

No discussions yet.